ケーススタディ 3: 再現性 (XP®モノクローナル抗体)

#9145 Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAbと#3230 Jak2 (D2E12) XP® Rabbit mAb

#9145 Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAbと#3230 Jak2 (D2E12) XP® Rabbit mAbを、ロットが異なっても安定した品質を実現する一例としてご紹介します。これは、CSTの厳格な品質管理とXMT®によるものです。

Western blot analysis of HeLa cells, untreated or treated with IFN-a.

Figure 2. Western blot analysis of K562 cells comparing lot 1, 3 and 5 of Jak2 (D2E12) XP® Rabbit mAb #3230, showing that signal remains consistent from lot to lot.

Western blot analysis of HeLa cells, untreated or treated with IFN-a.

Figure 1. Western blot analysis of HeLa cells, untreated or treated with IFN-α comparing lot 1, 2, 3 and 8 of Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAb #9145, showing that signal remains consistent from lot to lot. Note: Recommended dilution for western blot was changed to 1:2000 with release of lot 3.

Product Pathways

Tools

Applications